ALEXANDRIA, Va., July 10 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'BRIUMVI ONE' in its latest official gazette. The trademark application with the serial number 99840780 was filed on May 22, 2026.
Here are the other related details:
Goods and Services: 5 - Pharmaceutical preparations for human use, namely, pharmaceutical preparations for the prevention and treatment of multiple sclerosis
International/US Class(es): 5
Mark Drawing Code: 4 - STANDARD CHARACTER MARK
Current Owner(s): TG Therapeutics, Inc. 2 Gansevoort Street, 9th Floor New York NY New York 10014 3 CORPORATION
Disclaimer: Curated by HT Syndication....